Concepedia

Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer

Jonathan Wilkie, M. Alexandra Schickli, Michael Berger, Maryam B. Lustberg, Raquel E. Reinbolt, Anne M. Noonan, Bhuvaneswari Ramaswamy, Sagar Sardesai, Jeffrey VanDeusen, Robert Wesolowski,

Clinical Breast Cancer · 2019 · 46 citations · 4 references

DOI

Concepts

References

4

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn, Miguel Martín, Hope S. Rugo et al. · New England Journal of Medicine · 2016 · 2.8K citations

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Richard S. Finn, John Crown, István Láng et al. · The Lancet Oncology · 2014 · 1.9K citations

, , +11

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)

Sunil Verma, Cynthia Huang Bartlett, Patrick Schnell et al. · The Oncologist · 2016 · 243 citations · Full text

Abstract GS5-06: A U.S. food and drug administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapy

Harpreet Singh, LJ Howie, Erik Bloomquist et al. · Cancer Research · 2018 · 15 citations

, , +24